BioMed Central’s journal, BMC medicine has recently published new research, which investigates methods of preventing side effects that come with treatment of prostate cancer.

Prostate cancer continues to be one of the most common cancers found in males, and luckily, early detection and treatment is often successful.  In many cases of early prostate cancer detection, men who choose to get help with Androgen-suppression therapy find that it can come with unwanted side effects.

While Androgen-suppression therapy slows down the progression of prostate cancer by inhibiting testosterone, they can also cause breast enlargement in men, which stops many men from seeking early cancer treatment.

Combined data from clinical trials at German Cochrane Center and University Clinic Erlangen has yielded hope for management of breast growth and pain (during treatment) with tamoxifen.

Analysis of all the trails pooled shows that tamoxifen reduced both breast growth and pain at 3,6,9, and 12 months of treatment in comparison to men who have received no tamoxifen treatment.

Leader of the study, Frank Kunath, study leader, stated that “if men know that there is a successful option for reducing the breast symptoms associated with treatment for prostate cancer they may be more likely to see their doctor when symptoms of cancer first appear, and consequently reduce the number of unnecessary deaths.”

Seeking early treatment and support continues to be the greatest method to combat prostate cancer. Now that tamoxifen offers a relief from some of the uncomfortable side effects of early treatment, hopefully Frank Kunath’s prediction will come to pass.

If you or someone you know is experiencing the symptoms of prostate cancer but is apprehensive, healtheo360’s Prostate Cancer support group can offer you a means to reach others in the same situation.